Drug Description in Trials / DrugBank / KEGG DRUG /

  

Search results

No. 薬物名（臨床試験情報から抽出） DrugBank KEGG DRUG KEGG GENES KEGG PATHWAY 指定難病告示番号
1Autologous Umbilical Cord Blood----2件: 211, 294
2Bronchodilator Response----1件: 294
3Diagnostic Test: Fecal microbiome probiotic----1件: 294
4Diagnostic Test: Functional residual capacity----1件: 294
5Diagnostic Test: initial fecal microbiome----1件: 294
6Diagnostic Test: initial pulmonary microbiome----1件: 294
7Diagnostic Test: initial VOC----1件: 294
8Diagnostic Test: Maximum oxygen uptake1件: Oxygen1件: D00003 --1件: 294
9Diagnostic Test: Pulmonary microbiome probiotic----1件: 294
10Diagnostic Test: VOC probiotic----1件: 294
11Gold1件: Gold---43件: 2, 5, 6, 13, 17, 34, 35, 46, 49, 50, 53, 58, 65, 68, 76, 84, 86, 91, 93, 95, 96, 97, 98, 113, 137, 158, 162, 171, 193, 218, 222, 224, 227, 230, 235, 271, 291, 294, 296, 298, 299, 310, 318
12Hypersaline----1件: 294
13INALOSSIN - 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO BOMBOLA IN ALLUMINIO CON VALVOLA VI DA 20 LITRI----1件: 294
14INALOSSIN 800 PPM MOL/MOL GAS MEDICINALE COMPRESSO----1件: 294
15Inhaled Nitric Oxide (iNO) use1件: Nitric Oxide1件: D00074 --1件: 294
16INOmax1件: Nitric Oxide1件: D00074 --3件: 85, 294, 299
17INOmax 800ppm mol/mol inhalatiegas1件: Nitric Oxide1件: D00074 --1件: 294
18Losec1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬3件: 46, 225, 294
19Milrinone1件: Milrinone2件: D00417 ,
D02085 		2件: PDE3A,
PDE3B 💬		11件: Apelin signaling pathway, Glucagon signaling pathway, Insulin signaling pathway, Metabolic pathways, Morphine addiction, Progesterone-mediated oocyte maturation, Purine metabolism, Regulation of lipolysis in adipocytes, Renin secretion, cAMP signaling pathway, cGMP-PKG signaling pathway 💬1件: 294
20Neophyr 1000ppm mol/mol----1件: 294
21Nitric Oxide1件: Nitric Oxide1件: D00074 --8件: 46, 85, 86, 98, 210, 251, 294, 299
22Omeprazol1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 294
23Omeprazole1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬16件: 6, 8, 13, 21, 46, 51, 85, 96, 97, 98, 225, 271, 282, 294, 298, 299
24Omeprazole rectally 1mg/kg1件: Omeprazole4件: D00455 ,
D01207 ,
D05259 ,
D05261 		2件: ATP4A,
ATP4B 💬		4件: Collecting duct acid secretion, Gastric acid secretion, Metabolic pathways, Oxidative phosphorylation 💬1件: 294
25OSSIDO DI AZOTO----1件: 294
26Other: De-implementation of Inhaled Nitric Oxide (iNO) use1件: Nitric Oxide1件: D00074 --1件: 294
27Oxygen1件: Oxygen1件: D00003 --20件: 6, 13, 19, 46, 49, 70, 84, 85, 86, 88, 90, 96, 97, 168, 193, 226, 271, 294, 299, 330
28Probiotic treatment----1件: 294
29Repair of CDH w/Alloderm----1件: 294
30Repair of CDH w/SIS Gold1件: Gold---1件: 294
31REVATIO - 0.8 MG/ML - SOLUZIONE INIETTABILE - USO ENDOVENOSO - FLACONCINO(VETRO) 1 FLACONCINO DA 20 ML1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬1件: 294
32Revatio 0.8mg/ml solution for injection----1件: 294
33Sildenafil1件: Sildenafil2件: D02229 ,
D08514 		1件: PDE5A 💬3件: Metabolic pathways, Purine metabolism, cGMP-PKG signaling pathway 💬17件: 6, 46, 50, 51, 85, 86, 90, 113, 210, 211, 212, 225, 226, 278, 294, 299, 301